Patents by Inventor Robert E. McKean

Robert E. McKean has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL SOLID FORMS OF BENDAMUSTINE HYDROCHLORIDE
    Publication number: 20200323824
    Abstract: Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.
    Type: Application
    Filed: November 18, 2019
    Publication date: October 15, 2020
    Inventors: Martin Ian Cooper, Laurent D. Courvoisier, Mark Eddleston, Robert E. McKean
  • Solid forms of bendamustine hydrochloride
    Patent number: 10517852
    Abstract: Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.
    Type: Grant
    Filed: July 17, 2018
    Date of Patent: December 31, 2019
    Assignee: Cephalon, Inc.
    Inventors: Martin Ian Cooper, Laurent D. Courvoisier, Mark Eddleston, Robert E. McKean
  • NOVEL SOLID FORMS OF BENDAMUSTINE HYDROCHLORIDE
    Publication number: 20190015390
    Abstract: Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.
    Type: Application
    Filed: July 17, 2018
    Publication date: January 17, 2019
    Inventors: Martin Ian Cooper, Laurent D. Courvoisier, Mark Eddleston, Robert E. McKean
  • Solid forms of bendamustine hydrochloride
    Patent number: 10039750
    Abstract: Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.
    Type: Grant
    Filed: November 23, 2016
    Date of Patent: August 7, 2018
    Assignee: Cephalon, Inc.
    Inventors: Martin Ian Cooper, Laurent D. Courvoisier, Mark Eddleston, Robert E. McKean
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20180147186
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: January 24, 2018
    Publication date: May 31, 2018
    Applicant: IGNYTA, INC.
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • Bendamustine derivatives and methods of using same
    Patent number: 9913827
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: March 13, 2018
    Assignee: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. LaBell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20170182008
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: March 10, 2017
    Publication date: June 29, 2017
    Applicant: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. LaBell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • Bendamustine derivatives and methods of using same
    Patent number: 9630926
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: April 25, 2017
    Assignee: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. LaBell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • NOVEL SOLID FORMS OF BENDAMUSTINE HYDROCHLORIDE
    Publication number: 20170071913
    Abstract: Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.
    Type: Application
    Filed: November 23, 2016
    Publication date: March 16, 2017
    Inventors: Martin Ian Cooper, Laurent D. Courvoisier (Deceased), Mark Eddleston, Robert E. McKean
  • Solid forms of bendamustine hydrochloride
    Patent number: 9533955
    Abstract: Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.
    Type: Grant
    Filed: February 17, 2016
    Date of Patent: January 3, 2017
    Assignee: Cephalon, Inc.
    Inventors: Martin Ian Cooper, Laurent D. Courvoisier, Mark Eddleston, Robert E. McKean
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20160289198
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: June 16, 2016
    Publication date: October 6, 2016
    Applicant: Ignyta, Inc.
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • Bendamustine derivatives and methods of using same
    Patent number: 9452988
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: November 12, 2013
    Date of Patent: September 27, 2016
    Assignee: Ignyta, Inc.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. Labell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele, Bradley McIntyre
  • Novel Solid Forms Of Bendamustine Hydrochloride
    Publication number: 20160159748
    Abstract: Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.
    Type: Application
    Filed: February 17, 2016
    Publication date: June 9, 2016
    Inventors: Martin Ian Cooper, Laurent D. Courvoisier, Mark Eddleston, Robert E. McKean
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20160016912
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: September 28, 2015
    Publication date: January 21, 2016
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • Bendamustine derivatives and methods of using same
    Patent number: 9149464
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: October 6, 2015
    Assignee: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. Labell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • Bendamustine derivatives and methods of using same
    Patent number: 9150517
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Grant
    Filed: April 29, 2015
    Date of Patent: October 6, 2015
    Assignee: IGNYTA, INC.
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. Labell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20150274675
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: November 12, 2013
    Publication date: October 1, 2015
    Inventors: Roger P. Bakale, Peter D. Brown, Jian Chen, Anthony S. Drager, Rachel Y. Labell, Robert E. McKean, Piyush R. Patel, Renee C. Roemmele
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20150246023
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: May 13, 2015
    Publication date: September 3, 2015
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • BENDAMUSTINE DERIVATIVES AND METHODS OF USING SAME
    Publication number: 20150232427
    Abstract: The present invention is directed to bendamustine esters and bendamustine amides and their use for the treatment of cancer.
    Type: Application
    Filed: April 29, 2015
    Publication date: August 20, 2015
    Inventors: Roger P. BAKALE, Peter D. BROWN, Jian CHEN, Anthony S. DRAGER, Rachel Y. LABELL, Robert E. MCKEAN, Piyush R. PATEL, Renee C. ROEMMELE
  • Novel Solid Forms Of Bendamustine Hydrochloride
    Publication number: 20150051258
    Abstract: Novel solid forms of bendamustine hydrochloride are described, as well as methods of their preparation and use.
    Type: Application
    Filed: November 3, 2014
    Publication date: February 19, 2015
    Inventors: Martin Ian Cooper, Laurent D. Courvoisier, Mark Eddleston, Robert E. McKean